Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$392,144
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2016-04-01 McDonough Cameron Geoffrey Director Grant or award · Stock Option (Right to Buy) +6,100 6,100
2016-04-01 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +24,000 24,000
2016-04-01 Daniel Thomas O Director Grant or award · Stock Option (Right to Buy) +3,841 3,841
2016-03-31 Loustau Patrick President Grant or award · Stock Option (Right to Buy) +113,000 113,000
2016-03-31 Loustau Patrick President Grant or award · Stock Option (Right to Buy) +56,500 56,500
2016-03-31 Hughes Thomas E. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +249,000 249,000
2016-03-31 Hughes Thomas E. Chief Executive Officer Grant or award · Stock Option (Right to Buy) +124,500 124,500
2016-03-31 Secor Alicia Chief Commercial Officer Grant or award · Stock Option (Right to Buy) −53,000 53,000
2016-03-31 Secor Alicia Chief Commercial Officer Grant or award · Stock Option (Right to Buy) −26,500 26,500
2016-03-31 Allen Patricia L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +72,000 72,000
2016-03-31 Allen Patricia L Chief Financial Officer Grant or award · Stock Option (Right to Buy) +36,000 36,000
2016-03-31 KIM DENNIS D Chief Medical Officer Grant or award · Stock Option (Right to Buy) +75,000 75,000
2016-03-31 KIM DENNIS D Chief Medical Officer Grant or award · Stock Option (Right to Buy) +37,500 37,500
2016-02-12 Flynn James E 10% owner Purchase +22,296 $6.25 $139K 441,043
2016-02-12 Flynn James E 10% owner Purchase +28,377 $6.25 $177K 561,328
2016-02-12 Flynn James E 10% owner Purchase +13,872 $6.25 $87K 2,053,232
2016-02-11 Flynn James E 10% owner Purchase +810 $6.19 $5K 418,747
2016-02-11 Flynn James E 10% owner Purchase +1,030 $6.19 $6K 532,951
2016-02-11 Flynn James E 10% owner Purchase +504 $6.19 $3K 2,039,360
2016-02-10 Flynn James E 10% owner Purchase +52,239 $6.23 $326K 417,937

Page 12 of 15 · 296 trades